Dieras V, Curigliano G, Martin M, Lerebours F, et al. HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast Cancer. J Clin Oncol 2025 Dec 10:101200JCO2502600. doi: 10.1200/JCO-25-02600.
PMID: 41369677